Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties supportive of once-daily dosing in humans ACCG-2671 is the most ...
They can measure outrange values in key diseases, e.g., hyper- or hypoglycemia in diabetes. Currently, the prevalent use of nondegradable substrates and toxic metals in glycemia tests significantly ...